• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向癌症治疗中神经酰胺的递送系统:单独使用神经酰胺或与其他抗肿瘤药物联合使用。

Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.

作者信息

Ma Ying-Yu, Mou Xiao-Zhou, Ding Ya-Hui, Zou Hai, Huang Dong-Sheng

机构信息

a Clinical Research Institute , Zhejiang Provincial People's Hospital , Hangzhou , China.

b Medical School and Jiangsu Laboratory of Molecular Medicine , Nanjing University , Nanjing , China.

出版信息

Expert Opin Drug Deliv. 2016 Oct;13(10):1397-406. doi: 10.1080/17425247.2016.1188803. Epub 2016 May 25.

DOI:10.1080/17425247.2016.1188803
PMID:27168034
Abstract

INTRODUCTION

Ceramide is a bioactive lipid which functions as a tumor suppressor, regulating processes such as cell proliferation, differentiation, senescence and apoptosis. However, several challenges need to be overcome in order to realize the therapeutic potential of such a bioactive lipid combination regimen, including the hydrophobic and hemolytic nature of the lipids.

AREAS COVERED

In this review, we briefly describe the biological function of ceramide, then the delivery systems that have been developed to improve the pharmacology of ceramide have been summarized. In addition, combination therapies based on these delivery systems to reveal the interactions between therapeutic drugs and ceramide were also highlighted. Furthermore, future perspective before the extension of ceramide's applications in cancer treatment will also be discussed.

EXPERT OPINION

Although ceramide has attracted tremendous attention in targeted cancer treatment, its levels are usually suppressed by over-expression of ceramide-metabolizing enzymes or down-regulation of ceramide-generating enzymes. Thus, finding ways to increase ceramide by exogenous treatment in cancer cells is desired. Therefore, translating these bioactive lipids into clinical usage requires a variety of methods, and appropriately designed delivery systems may play the direct and important role in this process.

摘要

引言

神经酰胺是一种生物活性脂质,具有肿瘤抑制功能,可调节细胞增殖、分化、衰老和凋亡等过程。然而,为了实现这种生物活性脂质联合疗法的治疗潜力,需要克服几个挑战,包括脂质的疏水性和溶血性。

涵盖领域

在本综述中,我们简要描述了神经酰胺的生物学功能,然后总结了为改善神经酰胺药理学而开发的递送系统。此外,还强调了基于这些递送系统的联合疗法,以揭示治疗药物与神经酰胺之间的相互作用。此外,还将讨论神经酰胺在癌症治疗中应用扩展之前的未来前景。

专家观点

尽管神经酰胺在靶向癌症治疗中引起了极大关注,但其水平通常会因神经酰胺代谢酶的过度表达或神经酰胺生成酶的下调而受到抑制。因此,需要找到通过外源处理在癌细胞中增加神经酰胺的方法。因此将这些生物活性脂质转化为临床应用需要多种方法,而设计合理的递送系统可能在这一过程中发挥直接且重要的作用。

相似文献

1
Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.靶向癌症治疗中神经酰胺的递送系统:单独使用神经酰胺或与其他抗肿瘤药物联合使用。
Expert Opin Drug Deliv. 2016 Oct;13(10):1397-406. doi: 10.1080/17425247.2016.1188803. Epub 2016 May 25.
2
Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment.神经酰胺:癌症联合治疗中的治疗潜力。
Curr Drug Metab. 2015;17(1):37-51. doi: 10.2174/1389200216666151103120338.
3
Ceramide-based therapeutics for the treatment of cancer.基于神经酰胺的癌症治疗药物。
Anticancer Agents Med Chem. 2011 Nov;11(9):911-9. doi: 10.2174/187152011797655177.
4
The unfolding role of ceramide in coordinating retinoid-based cancer therapy.神经酰胺在协调视黄酸类癌症治疗中的作用不断显现。
Biochem J. 2021 Oct 15;478(19):3621-3642. doi: 10.1042/BCJ20210368.
5
Development and use of ceramide nanoliposomes in cancer.神经酰胺纳米脂质体在癌症中的研发与应用
Methods Enzymol. 2012;508:89-108. doi: 10.1016/B978-0-12-391860-4.00005-7.
6
Systemic Codelivery of a Homoserine Derived Ceramide Analogue and Curcumin to Tumor Vasculature Inhibits Mouse Tumor Growth.将一种高丝氨酸衍生的神经酰胺类似物和姜黄素系统共递送至肿瘤血管可抑制小鼠肿瘤生长。
Mol Pharm. 2016 Feb 1;13(2):404-19. doi: 10.1021/acs.molpharmaceut.5b00644. Epub 2016 Jan 15.
7
Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells.脂质体递送增强短链神经酰胺诱导的乳腺癌细胞凋亡。
J Pharmacol Exp Ther. 2003 Nov;307(2):468-75. doi: 10.1124/jpet.103.054056. Epub 2003 Sep 15.
8
Novel agents targeting bioactive sphingolipids for the treatment of cancer.新型靶向生物活性神经酰胺的药物治疗癌症。
Curr Med Chem. 2013;20(1):108-22.
9
Roles and therapeutic targeting of ceramide metabolism in cancer.鞘脂代谢在癌症中的作用和治疗靶点。
Mol Metab. 2024 May;83:101936. doi: 10.1016/j.molmet.2024.101936. Epub 2024 Apr 9.
10
A review of ceramide analogs as potential anticancer agents.神经酰胺类似物作为潜在抗癌剂的研究进展。
Future Med Chem. 2013 Aug;5(12):1405-21. doi: 10.4155/fmc.13.107.

引用本文的文献

1
Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma.胶质母细胞瘤抗血管生成疗法耐药机制中的最新治疗策略和分子途径
Cancers (Basel). 2024 Aug 27;16(17):2975. doi: 10.3390/cancers16172975.
2
Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion.细胞膜鞘磷脂:在癌症发生、进展和免疫逃逸中的关键作用。
Lipids Health Dis. 2021 Oct 31;20(1):150. doi: 10.1186/s12944-021-01581-y.
3
Emerging insights into mitochondria-specific targeting and drug delivering strategies: Recent milestones and therapeutic implications.
线粒体特异性靶向与药物递送策略的新见解:近期进展与治疗意义
Saudi J Biol Sci. 2020 Dec;27(12):3581-3592. doi: 10.1016/j.sjbs.2020.07.030. Epub 2020 Aug 1.
4
Effect of 1α,25(OH) Vitamin D in Mutant P53 Glioblastoma Cells: Involvement of Neutral Sphingomyelinase1.1α,25(OH)维生素D对突变型P53胶质母细胞瘤细胞的影响:中性鞘磷脂酶1的作用
Cancers (Basel). 2020 Oct 28;12(11):3163. doi: 10.3390/cancers12113163.
5
Unique Roles of Sphingolipids in Selected Malignant and Nonmalignant Lesions of Female Reproductive System.鞘脂类在女性生殖系统某些良恶性病变中的独特作用。
Biomed Res Int. 2019 May 2;2019:4376583. doi: 10.1155/2019/4376583. eCollection 2019.
6
Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.新型基于神经酰胺的癌症治疗药物在个性化医疗时代的应用
Adv Cancer Res. 2018;140:327-366. doi: 10.1016/bs.acr.2018.04.016. Epub 2018 Jun 19.
7
Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency.基于神经酰胺脂质的纳米混悬液用于增强多西他赛的递送并具有协同抗肿瘤效果。
Drug Deliv. 2017 Nov;24(1):800-810. doi: 10.1080/10717544.2016.1225853.